Literature DB >> 34169474

Optimizing patient centered care in the cardiac intensive care unit: Harness the safety, effectiveness, and incremental value of radionuclide perfusion, function, and molecular imaging.

Peter A Bleszynski1, Ronald G Schwartz2,3.   

Abstract

Entities:  

Year:  2021        PMID： 34169474     DOI： 10.1007/s12350-021-02691-x

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  12 in total

1.  Nuclear imaging for patients with a suspicion of infective endocarditis: Be part of the team!

Authors:  Fabien Hyafil; François Rouzet; Dominique Le Guludec
Journal:  J Nucl Cardiol       Date:  2015-12-29       Impact factor: 5.952

2.  Extent of Myocardial Ischemia on Positron Emission Tomography and Survival Benefit With Early Revascularization.

Authors:  Krishna K Patel; John A Spertus; Paul S Chan; Brett W Sperry; Randall C Thompson; Firas Al Badarin; Kevin F Kennedy; James A Case; Staci Courter; Ibrahim M Saeed; A Iain McGhie; Timothy M Bateman
Journal:  J Am Coll Cardiol       Date:  2019-10-01       Impact factor: 24.094

Review 3.  Serious and potentially life threatening complications of cardiac stress testing: Physiological mechanisms and management strategies.

Authors:  Vasken Dilsizian; Henry Gewirtz; Nicholas Paivanas; Anastasia N Kitsiou; Fadi G Hage; Nathan E Crone; Ronald G Schwartz
Journal:  J Nucl Cardiol       Date:  2015-05-15       Impact factor: 5.952

4.  Optimizing cardiac sarcoid imaging with FDG PET: Lessons from studies of physiologic regulation of myocardial fuel substrate utilization.

Authors:  Ronald G Schwartz; Saurabh Malhotra
Journal:  J Nucl Cardiol       Date:  2018-09-17       Impact factor: 5.952

Review 5.  18F-fluorodeoxyglucose positron emission/computed tomography and computed tomography angiography in prosthetic heart valve endocarditis: from guidelines to clinical practice.

Authors:  Laurens E Swart; Asbjørn M Scholtens; Wilco Tanis; Koen Nieman; Ad J J C Bogers; Fred J Verzijlbergen; Gabriel P Krestin; Jolien W Roos-Hesselink; Ricardo P J Budde
Journal:  Eur Heart J       Date:  2018-11-01       Impact factor: 29.983

6.  Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial.

Authors:  Gianni D'Egidio; Graham Nichol; Kathryn A Williams; Ann Guo; Linda Garrard; Robert deKemp; Terrence D Ruddy; Jean DaSilva; Dennis Humen; Karen Y Gulenchyn; Michael Freeman; Normand Racine; Francois Benard; Paul Hendry; Rob S B Beanlands
Journal:  JACC Cardiovasc Imaging       Date:  2009-09

7.  Aminophylline and caffeine for reversal of adverse symptoms associated with regadenoson SPECT MPI.

Authors:  Jesse A Doran; Waseem Sajjad; Marabel D Schneider; Rohit Gupta; Maria L Mackin; Ronald G Schwartz
Journal:  J Nucl Cardiol       Date:  2016-03-29       Impact factor: 5.952

8.  Comparison of rest-redistribution thallium-201 imaging and reinjection after stress-redistribution for the assessment of myocardial viability in patients with left ventricular dysfunction secondary to coronary artery disease.

Authors:  A R Galassi; G Centamore; A Fiscella; A Coppola; F Liberti; M Franco; G Palazzo; S Musumeci; A Galassi
Journal:  Am J Cardiol       Date:  1995-03-01       Impact factor: 2.778

9.  First validation of myocardial flow reserve assessed by dynamic 99mTc-sestamibi CZT-SPECT camera: head to head comparison with 15O-water PET and fractional flow reserve in patients with suspected coronary artery disease. The WATERDAY study.

Authors:  Denis Agostini; Vincent Roule; Catherine Nganoa; Nathaniel Roth; Raphael Baavour; Jean-Jacques Parienti; Farzin Beygui; Alain Manrique
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-03-01       Impact factor: 9.236

10.  The additional prognostic value of myocardial perfusion SPECT in patients with known coronary artery disease with high exercise capacity.

Authors:  Thais R Peclat; Ana Carolina do A H de Souza; Victor F Souza; Aline M K Nakamoto; Felipe M Neves; Izabella C R Silva; Ronaldo S L Lima
Journal:  J Nucl Cardiol       Date:  2019-12-02       Impact factor: 5.952
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.